CH659586A5 - Arzneimittel aus dem thymus und verfahren zu dessen herstellung. - Google Patents

Arzneimittel aus dem thymus und verfahren zu dessen herstellung. Download PDF

Info

Publication number
CH659586A5
CH659586A5 CH2550/84A CH255084A CH659586A5 CH 659586 A5 CH659586 A5 CH 659586A5 CH 2550/84 A CH2550/84 A CH 2550/84A CH 255084 A CH255084 A CH 255084A CH 659586 A5 CH659586 A5 CH 659586A5
Authority
CH
Switzerland
Prior art keywords
thymus
polypeptides
acetic acid
precipitate
tissue
Prior art date
Application number
CH2550/84A
Other languages
German (de)
English (en)
Inventor
Vyacheslav Grigorievic Morozov
Vladimir Khatskelevi Khavinson
Original Assignee
Le G Ped I
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Le G Ped I filed Critical Le G Ped I
Publication of CH659586A5 publication Critical patent/CH659586A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/26—Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57581—Thymosin; Related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
CH2550/84A 1985-07-02 1984-05-24 Arzneimittel aus dem thymus und verfahren zu dessen herstellung. CH659586A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB08516697A GB2177402A (en) 1985-07-02 1985-07-02 Thymus-gland preparation and method for producing same

Publications (1)

Publication Number Publication Date
CH659586A5 true CH659586A5 (de) 1987-02-13

Family

ID=10581651

Family Applications (1)

Application Number Title Priority Date Filing Date
CH2550/84A CH659586A5 (de) 1985-07-02 1984-05-24 Arzneimittel aus dem thymus und verfahren zu dessen herstellung.

Country Status (5)

Country Link
JP (1) JPS60258120A (da)
CH (1) CH659586A5 (da)
DE (1) DE3421789A1 (da)
FR (1) FR2583982B1 (da)
GB (1) GB2177402A (da)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT4393B (lt) 1995-03-02 1998-10-26 Immunotech Developments Inc. Peptidas ir jo gavimo būdas
LT4476B (lt) 1995-06-07 1999-03-25 Vladislav Isakovich Deigin Peptidas ir jo gavimo būdas
US6100380A (en) * 1991-10-28 2000-08-08 Cytran, Inc. Immunomodulating peptides and methods of use
US6368788B1 (en) 1987-12-30 2002-04-09 Cytran, Inc. Method of treating complications in immunodepressed states resulting from HIV infection

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1196958B (it) * 1986-07-10 1988-11-25 Ellem Ind Farmaceutica Derivato di timo attivo per via orale, procedimenti per la sua preparazione e relative composizioni farmaceutiche
DE3633651A1 (de) * 1986-10-03 1988-04-14 Alfred Dr Dick Verwendung von fraktionen aus thymus- und milzextrakten zur behandlung der psoriasis
US5811399A (en) * 1988-12-14 1998-09-22 Cytran, Inc. Pharmaceutical dipeptide compositions and methods of use thereof: immunodepressants
JPH0365161A (ja) * 1989-08-01 1991-03-20 Marudai Shokuhin Kk 機能性食品
US6066622A (en) * 1991-10-28 2000-05-23 Cytran, Inc. Immunomodulating peptides and methods of use
RU2290936C1 (ru) * 2006-01-31 2007-01-10 Общество С Ограниченной Ответственностью "Сиа Пептайдс" Способ получения средства для поддерживающей терапии, обладающего тканеспецифической активностью
RU2648466C1 (ru) * 2016-11-01 2018-03-26 Федеральное государственное бюджетное образовательное учреждение высшего образования "Воронежский государственный университет инженерных технологий" (ФГБОУ ВО "ВГУИТ") Способ получения биогенного стимулятора для лечения и профилактики заболеваний сельскохозяйственных животных

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU934589A1 (ru) * 1980-06-16 1985-06-30 Военно-Медицинская Ордена Ленина Краснознаменная Академия Им.С.М.Кирова Способ получени полипептидов
FR2492663B1 (fr) * 1980-10-24 1985-11-08 Vtoroi Mo G Produit medicamenteux regulateur du t-systeme de l'immunite et son procede de preparation
DE3175462D1 (en) * 1981-11-26 1986-11-20 Ollendiek Heinrich Thymus extraction process
EP0122926A4 (en) * 1982-09-20 1987-01-20 Endorphin Inc IMMUNIZING STIMULATOR.

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6368788B1 (en) 1987-12-30 2002-04-09 Cytran, Inc. Method of treating complications in immunodepressed states resulting from HIV infection
US6777195B2 (en) 1987-12-30 2004-08-17 Cytran, Inc. Pharmaceutical dipeptide compositions and methods of use thereof: immunostimulants
US6100380A (en) * 1991-10-28 2000-08-08 Cytran, Inc. Immunomodulating peptides and methods of use
LT4393B (lt) 1995-03-02 1998-10-26 Immunotech Developments Inc. Peptidas ir jo gavimo būdas
LT4476B (lt) 1995-06-07 1999-03-25 Vladislav Isakovich Deigin Peptidas ir jo gavimo būdas

Also Published As

Publication number Publication date
DE3421789A1 (de) 1985-12-12
FR2583982A1 (fr) 1987-01-02
DE3421789C2 (da) 1988-10-06
GB2177402A (en) 1987-01-21
FR2583982B1 (fr) 1989-02-24
GB8516697D0 (en) 1985-08-07
JPH0247966B2 (da) 1990-10-23
JPS60258120A (ja) 1985-12-20

Similar Documents

Publication Publication Date Title
EP0207956B1 (de) Hirudin-pa und dessen derivate, verfahren zu deren herstellung und deren verwendung
DE3485945T2 (de) Gereinigter transformierender wachstum-beta-faktor aus humanen plaketten und plazenten stammend.
EP0346501B1 (de) Arzneimittelzubereitung zur behandlung des immunmangels
CH659586A5 (de) Arzneimittel aus dem thymus und verfahren zu dessen herstellung.
EP0101063B1 (de) Neues Polypeptid mit Wirkung auf das Immunsystem, Verfahren zu seiner Isolierung und Reinigung, seine Verwendung und dieses enthaltende Mittel
EP0457370B1 (de) Verfahren zur Pasteurisierung des Gewebeproteins PP4
DE1949195A1 (de) Verfahren zur Herstellung deproteinisierter Bluextrakte mit Heilwirkung
DE3687097T2 (de) Therapeutisches mittel zur behandlung haematopoietischer krankheiten.
DE68911693T2 (de) Pharmazeutisches mittel für behandlung von menschlichem krebs und verfahren zu seiner herstellung.
EP0894094A1 (de) Verfahren zur gewinnung eines komplexes aus wachstumsfaktoren
US5070076A (en) Thymus-gland preparation and method for producing same
DE69928375T2 (de) Analgetikum aus schlangengift
DE2857532C1 (de) Therapeutisches Mittel zur Wundbehandlung und Verfahren zu seiner Herstellung
DE3306944C2 (da)
DE1940130C2 (de) Verfahren zur Reinigung von Insulin, nach diesem Verfahren gereinigtes Insulin und dessen Verwendung
DE2558537C2 (de) Verfahren zum Isolieren von Substanzen mit insulinähnlicher Wirksamkeit aus Blut oder Blutbestandteilen von Kälbern oder Schweinen
DE69126563T2 (de) Verwendung einer Mischung von Peptiden and Aminosäuren für die Prophylaxis oder Behandlung von Dementia
DE2720041A1 (de) Herzstaerkendes mittel
AT392003B (de) Verfahren zur herstellung eines insbesondere zur wundheilung oder zur behandlung in der geriatrie verwendbaren wirkstoffes aus saeugetierblut durch papainhydrolyse und ein einen solchen wirkstoff enthaltendes praeparat
DE1617332A1 (de) Verfahren zur Isolierung eines Proteins
EP0493494A1 (de) Neue proteine geeignet zur bekämpfung von krankheiten sowie zum schutz von weidevieh gegen zecken
EP0133308B1 (de) Appetitregulierender Wirkstoff und Verfahren zur Herstellung desselben
RU2033796C1 (ru) Пептидсодержащая фракция из селезенки млекопитающих, обладающая иммуностимулирующей активностью и способ ее получения
DE3034529C2 (de) Leukorekrutin: Ein Entzündungsmediatorprotein aus Säugerserum zur Induzierung einer Leukozytosereaktion, Herstellungsverfahren, Gewinnung in molekular einheitlicher, kristallisierbarer und biologisch spezifisch wirkender Form und Leukorekrutin enthaltendes Arzneimittel
RU2036651C1 (ru) Биогенный стимулятор для лечения и профилактики заболеваний сельскохозяйственных животных

Legal Events

Date Code Title Description
PL Patent ceased